Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Emmet Keeffe Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Profiles
Journals
Review Articles
Slide Atlas
Video Clips
Systematic Reviews
Meta-analyses
Guidelines
Online Books
Advanced Digestive Endoscopy
Lectures
Classical Cases
Personal View
Quiz
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links
APT cover

Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS
link to aasld.org

News

Deaths occurring in a fecal occult blood screening for colorectal cancer

The latest issue of Gut analyzes deaths occurring in a fecal occult blood screening for colorectal cancer.

News image

Professor David Whynes and colleagues from the United Kingdom reported the causes of, and ages at, death of subjects in an English colorectal cancer screening trial.

The research team analyzed 78,708 deaths occurring between 1981 and 2008, within the Nottingham randomised controlled trial of biennial faecal occult blood testing.

The team's main outcome measures included Cause of death, age at death by sex and by cause.

The research team noted that significantly more subjects died from verified colorectal cancer in the trial's control group than in the intervention group.

For no other major cause of death was the difference in proportion across the two groups statistically significant.

Subjects receiving negative test results lived significantly longer
Gut

The research team observed that age at death was lower for cancer than for other principal causes, except for ischemic heart disease among women.

However, mean age at death was higher for colorectal cancer than for other cancers, except for prostate cancer among men.

The researchers noted that increasing levels of material deprivation significantly lowered the expected ages at death, independently of cause.

For both men and women, the team found that the mean age at death from all causes for screening participants was higher than that of controls and non-participants.

Mean deprivation was lowest among participants.

Of those participating in screening, and dying from colorectal cancer, subjects receiving negative test results lived significantly longer than those who received positive test results.

However, if dying from other causes, they died at an earlier age.

Professor Whynes' team concludes, "The age at death from colorectal cancer is higher than that of most other cancers."

Gut 2010: 59: 1088-93
26 July 2010

Go to top of page Email this page Email this page to a colleague

 06 September 2010

Advanced search
 06 September 2010 
Endoscopy and treatment of obesity
 06 September 2010 
Simple non-invasive fibrosis scoring system
 06 September 2010 
Risk for pouch neoplasia after restorative proctocolectomy
 03 September 2010 
Genetic variants associated with colorectal cancer
 03 September 2010 
Risk for surgery in pediatric Crohn's
 03 September 2010 
Outcomes in severe ulcerative colitis
 02 September 2010 
Risk of colorectal cancer in screenees
 02 September 2010 
Predicting clinical outcomes in liver disease
 02 September 2010 
Recurrent venous thromboembolism
 01 September 2010 
Natural history of Crohn's disease
 01 September 2010 
Mortality among undiagnosed celiac disease
 01 September 2010 
Sedation for colonoscopy and EGD in the United States
 31 August 2010 
Noninvasive prediction of esophageal varices
 31 August 2010 
Medical treatment of Crohn's disease
 31 August 2010 
Determining surveillance of colonic polyps
 30 August 2010 
Beta-blockers in patients refractory ascites
 30 August 2010 
Sustained virological response in HCV
 30 August 2010 
Trastuzumab for advanced gastric cancer
 27 August 2010 
Cognitive functioning and age in senior surgeons
 27 August 2010 
Lifestyle and polyp detection on screening
 27 August 2010 
Antibiotics reduce infection following colectomy
 26 August 2010 
Socioeconomic status predicts operative mortality
 26 August 2010 
Mesenteric embolization for lower GI bleeding
 26 August 2010 
Follow-up of open vs laparoscopic appendicectomy
 25 August 2010 
Wholegrains and risk of colorectal cancers
 25 August 2010 
Alcohol intake and risk of colorectal cancer
 24 August 2010 
Score to identify colectomy risk
 24 August 2010 
Microbiota alteration from donor flora
 24 August 2010 
Complicated hernia with cirrhosis and refractory ascites
 23 August 2010 
Perceptions of medication safety in IBD patients
 23 August 2010 
Laparoscopic peritoneal lavage for perforated diverticulitis
 23 August 2010 
Pentavalent rotavirus vaccine in sub-Saharan Africa
 20 August 2010 
Predicting outcome in acute liver failure
 20 August 2010 
Persistent reflux on PPI therapy
 20 August 2010 
Celiacs without villous atrophy
 19 August 2010 
Gender variation of IBS symptoms
 19 August 2010 
Centralization improves rectal cancer outcomes
 19 August 2010 
Mortality from peptic ulcer bleeding
 18 August 2010 
Eosinophilic esophagitis epidemiology
 18 August 2010 
Care in patients with chronic HCV
 18 August 2010 
Operative mortality in resource-limited settings
 17 August 2010 
Achalasia in a Canadian population
 17 August 2010 
Steatosis as a risk in hepatic resection
 17 August 2010 
Renal failure associated with hepatitis A
 16 August 2010 
Oral bisphosphonates and esophageal cancer
 16 August 2010 
Surveillance of dysplasia in ulcerative colitis
 16 August 2010 
Missed cancers after esophagogastroduodenoscopy
 13 August 2010 
Guidelines for surveillance colonoscopies
 13 August 2010 
Metastatic colorectal patients' outcome
 13 August 2010 
Treatment response in functional bowel disorders
 12 August 2010 
Renal transplants in chronic Hep B
 12 August 2010 
Endoscopic resection for Barrett's dysplasia
 12 August 2010 
Infliximab dosing on maintenance therapy in Crohn's
 11 August 2010 
Treatment for metastatic colorectal cancer
 11 August 2010 
Bacterial infections with pouchitis
 11 August 2010 
Cancer risk in Peutz–Jeghers syndrome
 10 August 2010 
Laparoscopic vs open mesh repair for inguinal hernia
 10 August 2010 
Guidelines to select endoscopy patients
 10 August 2010 
Stability of IBS over time
 09 August 2010 
Determinants of spontaneous Hep B antigen clearance

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2010 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us